O‘PKA RAKINI ANIQLASHDA MSKTNING AHAMIYATI
Keywords:
Kalit so’zlar: O‘pka saratoni, MSKT (past dozali KT), o‘pka skriningi, o‘pka nodullari, erta tashxis, chekish, radiologik tekshiruvAbstract
Annotatsiya: O‘pka saratoni dunyo bo‘yicha saraton bilan bog‘liq o‘limlarning yetakchi sabablaridan biri hisoblanadi. Jahon sog‘liqni saqlash tashkiloti ma’lumotlariga ko‘ra, 2022-yilda dunyoda o‘pka saratoni tufayli 1,8 milliondan ortiq o‘lim holati qayd etilgan. Erkaklarda kasallanish va o‘lim ko‘rsatkichlari ayollarga nisbatan yuqori bo‘lib, o‘lim holatlarining taxminan 67–68 % erkaklar hissasiga to‘g‘ri keladi. O‘zbekistonda erkaklarda o‘pka saratoni eng ko‘p uchraydigan xavfli o‘smalardan biri hisoblanadi, Rossiyada esa erkaklar orasida yetakchi onkologik kasalliklardan biri sifatida qayd etiladi.
References
1. Callister ME, et al. (2015). BTS guidelines for pulmonary nodules. Thorax.
2. MacMahon H, et al. (2017). Fleischner Society guidelines. Radiology.
3. Horeweg N, et al. (2014). Detection of lung cancer in NELSON screening. Lancet Oncology.
4. Oudkerk M, et al. (2017). European lung cancer screening recommendations. Lancet Oncology.
5. Silva M, et al. (2018). CT screening and nodule management. Radiology.
6. Xu DM, et al. (2015). Lung cancer screening CT findings. Chest.
7. Henschke CI, et al. (2006). Early lung cancer CT screening results. NEJM.
8. Katki HA, et al. (2016). Risk prediction in lung nodules. JAMA.
9. Horeweg N, et al. (2015). Nodule growth rate in NELSON trial. Radiology.
10. Field JK, et al. (2016). Lung cancer screening overview. Lancet.
11. Pastorino U, et al. (2019). Lung cancer screening outcomes. Ann Oncol.
12. Mazzone PJ, et al. (2018). ACCP lung nodule guidelines. Chest.
13. Gould MK, et al. (2013). Evaluation of pulmonary nodules. Chest.
14. Veronesi G, et al. (2017). Screening CT and mortality. J Clin Oncol.
15. De Hoop B, et al. (2010). CT screening nodule detection. Radiology.
16. Baldwin DR, et al. (2011). Lung cancer screening evidence review. Thorax.
17. Horeweg N, et al. (2013). Nodule management strategy in NELSON. Radiology.
18. Van Klaveren RJ, et al. (2009). NELSON trial design. Eur Radiol.
19. Black WC, et al. (2014). Cost-effectiveness of lung screening. J Natl Cancer Inst.
20. Wender R, et al. (2013). USPSTF lung cancer screening. Ann Intern Med.
21. Zhong D, et al. (2024). Lung Nodule Management in LDCT screening
22. Aberle DR, et al. (2011). Reduced lung-cancer mortality with low-dose CT screening. NEJM.
23. de Koning HJ, et al. (2020). Reduced lung-cancer mortality in the NELSON trial. NEJM.
24. National Lung Screening Trial Research Team. (2011). Results of the NLST. NEJM.
25. McWilliams A, et al. (2013). Probability of cancer in pulmonary nodules. NEJM.
